Company Overview and News

0
Large builders eye township projects as small firms exit

2018-06-17 livemint
Smaller and regional developers are slowly exiting the business of building townships because of funding challenges, scarcity of land and stringent regulatory norms, leaving a few large firms to rule this space.
GODREJPROP 533150

4
Deutsche Bank attributes slowdown in realty stocks to new accounting standards

2018-06-15 moneycontrol
Highlighting the fact that real estate stocks this year have been underperforming the broader markets, Deutsche Bank believes that it could be linked to uncertainties around new accounting standards.
GODREJPROP OBZIY DB OBEROIRLTY 533150 533273

0
Godrej Properties raises Rs 1,000 cr via pref. issue

2018-06-08 thehindubusinessline
Godrej Properties has raised Rs 1,000 crore through issue of preferential shares to a GIC-managed investment firm.
GODREJPROP 533150

0
Godrej Properties raises Rs 1,000 cr from GIC-managed firm

2018-06-08 moneycontrol
Realty firm Godrej Properties today said it has raised Rs 1,000 crore through issue of preferential shares to a GIC-managed investment firm.
GODREJPROP 533150

0
Godrej Properties raises Rs1,000 crore from GIC-managed firm

2018-06-08 livemint
New Delhi: Realty firm Godrej Properties Ltd on Friday said it has raised Rs1,000 crore through issue of preferential shares to a GIC-managed investment firm.
GODREJPROP 533150

0
Godrej Properties Limited - Allotment of Securities

2018-06-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GODREJPROP 533150

30
Market Update: Realty, infra stocks gain ahead of RBI policy; Lupin, Sun Pharma up 1-2%

2018-06-06 moneycontrol
The broader indices are trading on a negative note this Wednesday morning ahead of the RBI monetary policy which is scheduled later in the day. The Nifty is trading higher by 15 points at 10,608 and the Sensex gained 52 points at 34,955.
524715 533150 533096 GREENFIRE 512573 532714 532712 BHRQY 532832 533278 ABAN JUSTDIAL 535648 532187 RCOM HDFCBANK BHARTIARTL KEC CLNDY 503100 YESBANK PHOENIXLTD AVANTI INDUSINDBK 590057 IBN 532648 YYBKY 532454 500380 ICICIBANK GODREJPROP HDB 532174 500180 SUNPHARMA 534809 ADANIPOWER JKLAKSHMI PCJEWELLER 523204 COALINDIA JSTQY IBREALEST

0
Godrej Properties Limited - Allotment of ESOP/ESPS

2018-06-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GODREJPROP 533150

0
Godrej Properties Limited - Shareholders meeting

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GODREJPROP 533150

0
Godrej Properties Limited - Shareholders meeting

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GODREJPROP 533150

0
DLF sells office space in Gurugram for Rs150 crore

2018-05-27 livemint
New Delhi: India’s largest realty firm DLF has sold nearly 50,000 sq ft of prime office space in Gurugram for about Rs150 crore on account of rising demand for commercial properties from corporates and institutional investors.
GODREJPROP 533150 KIMTF KIMTY

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...